Cisplatin induces stemness in ovarian cancer

The mainstay of treatment for ovarian cancer is platinum-based cytotoxic chemotherapy. However, therapeutic resistance and recurrence is a common eventuality for nearly all ovarian cancer patients, resulting in poor median survival. Recurrence is postulated to be driven by a population of self-renew...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Wiechert, Andrew, Saygin, Caner, Thiagarajan, Praveena S., Rao, Vinay S., Hale, James S., Gupta, Nikhil, Hitomi, Masahiro, Nagaraj, Anil Belur, DiFeo, Analisa, Lathia, Justin D., Reizes, Ofer
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5058697/
https://ncbi.nlm.nih.gov/pubmed/27105520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8852
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak